Hartaj Singh, Oppenheimer Analyst, joins Yahoo Finance to discuss downgrading Moderna earlier this month, future outlook on the stock, and questions around booster shots.
Got a news tip or correction? Let us know
If you got something out of this, please chip in to keep this site running, or subscribe to go ad-free.
3 views